Vasculoprotective effects of 3-hydroxybenzaldehyde against VSMCs proliferation and ECs inflammation

Medicine and Dentistry

• 3 Hydroxybenzaldehyde 100%
• Vascular Smooth Muscle Cell 40%
• Cell Proliferation 20%
• Protocatechualdehyde 20%
• In Vitro 10%
• Serositis 10%
• Phosphorylation 10%
• Angiogenesis 10%
• Matrigel 10%
• Cell Migration 10%
• Intercellular Adhesion Molecule 1 10%
• Circulation 10%
• Endothelial Cell 10%
• Therapeutic Agent 10%
• Human Umbilical Vein Endothelial Cell 10%
• Signaling Molecule 10%
• Adenosine Diphosphate 10%
• Vascular Cell Adhesion Molecule 1 10%
• Cell Cycle 10%
• Ex Vivo 10%
• Precursor 10%
• Phenol Derivative 10%
• Neointima 10%
• Common Carotid Artery 10%
• G1 Phase 10%
• Platelet Derived Growth Factor 10%
• Injury 10%
• BrdU Assay 10%
• Assay 10%
• Marker 10%

Pharmacology, Toxicology and Pharmaceutical Science

• 3 Hydroxybenzaldehyde 100%
• Thrombus 20%
• Protocatechualdehyde 20%
• Rat 20%
• Matrigel 10%
• Adenosine Diphosphate 10%
• Animal 10%
• Intercellular Adhesion Molecule 1 10%
• Vascular Cell Adhesion Molecule 1 10%
• Neointima 10%
• Platelet Derived Growth Factor 10%
• Injury 10%
• Mouse 10%